Key Data For Amgen Medicines In Relapsed Multiple Myeloma And Acute Lymphoblastic Leukemia To Be Presented At ASH 2015 Read more about Key Data For Amgen Medicines In Relapsed Multiple Myeloma And Acute Lymphoblastic Leukemia To Be Presented At ASH 2015
Amgen Highlights Data To Be Presented At 2015 American College Of Rheumatology And Association For Rheumatology Health Professionals Annual Meeting Read more about Amgen Highlights Data To Be Presented At 2015 American College Of Rheumatology And Association For Rheumatology Health Professionals Annual Meeting
Amgen To Highlight Cardiovascular Portfolio At American Heart Association Scientific Sessions 2015 Read more about Amgen To Highlight Cardiovascular Portfolio At American Heart Association Scientific Sessions 2015
Amgen's Third Quarter 2015 Revenues Increased 14 Percent To $5.7 Billion And Adjusted Earnings Per Share (EPS) Increased 18 Percent To $2.72 Read more about Amgen's Third Quarter 2015 Revenues Increased 14 Percent To $5.7 Billion And Adjusted Earnings Per Share (EPS) Increased 18 Percent To $2.72
FDA Approves IMLYGIC™ (Talimogene Laherparepvec) As First Oncolytic Viral Therapy In The US Read more about FDA Approves IMLYGIC™ (Talimogene Laherparepvec) As First Oncolytic Viral Therapy In The US
Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure Read more about Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure
Amgen Announces Webcast of 2015 Third Quarter Financial Results Read more about Amgen Announces Webcast of 2015 Third Quarter Financial Results
Amgen Receives CHMP Positive Opinion For IMLYGIC™ (Talimogene Laherparepvec) Read more about Amgen Receives CHMP Positive Opinion For IMLYGIC™ (Talimogene Laherparepvec)
Amgen Foundation Announces New $4 Million Commitment to Bring Hands-On Biotechnology Labs to Secondary School Students Read more about Amgen Foundation Announces New $4 Million Commitment to Bring Hands-On Biotechnology Labs to Secondary School Students
Amgen Announces 2015 Fourth Quarter Dividend Read more about Amgen Announces 2015 Fourth Quarter Dividend
